Cargando…

A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes

Background: Insulin glargine provides effective glycemic control when administered at bedtime in adults. Objective: This study aims to investigate whether insulin glargine is equally effective if administered in the morning or at bedtime in combination with preprandial anologue insulin. Methods: Twe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gökşen Şimşek, Damla, Yıldız, Başak, Asar, Gülgün, Darcan, Şükran
Formato: Texto
Lenguaje:English
Publicado: Galenos Publishing 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005638/
https://www.ncbi.nlm.nih.gov/pubmed/21318060
http://dx.doi.org/10.4008/jcrpe.v1i1.10
_version_ 1782194111544033280
author Gökşen Şimşek, Damla
Yıldız, Başak
Asar, Gülgün
Darcan, Şükran
author_facet Gökşen Şimşek, Damla
Yıldız, Başak
Asar, Gülgün
Darcan, Şükran
author_sort Gökşen Şimşek, Damla
collection PubMed
description Background: Insulin glargine provides effective glycemic control when administered at bedtime in adults. Objective: This study aims to investigate whether insulin glargine is equally effective if administered in the morning or at bedtime in combination with preprandial anologue insulin. Methods: Twenty−eight patients that have been treated with an intensified insulin regimen for at least one year were randomized to insulin glargine injection at breakfast (06:00−09:00) (12 patients) or bedtime (21:00−24:00) (16 patients), plus meal−time anologue insulin in the two groups. Glucose data from each day were analyzed at four different times: between 9:00 and 21:00 (t1), between 21:00 and 24:00 (t2), between 24:00 and 04:00 (t3),04:00 and 09:00 (t4) by the Minimed continuous glucose monitoring system. Results: Baseline characteristics were similar in the two groups. The sensor values were lower before breakfast in the bedtime group (180.5 ± 49.0 vs 223.8 ± 47.3 mg/dl, p=0.03). There were 13.7 events.patient (−1).day(−1) in the bedtime group and 6.9 events.patient (−1).day(−1) in the breakfast group in which glucose levels fell below 60 mg/dl (p=0.3). There were 121.6 events.patient (−1).day(−1) in the bedtime group and 162.4 events.patient (−1).day(−1) in the breakfast group in which glucose levels exceeded 180 mg/dl (p=0.05). Nighttime hypoglycemia only reached to a statistical significance between the two groups between 24:00 and 04:00. There were no significant correlations between the duration of nocturnal hypoglycemia, age, duration of diabetes, gender and HbA1c levels. Conclusion: Breakfast group is hyperglycemic during the day and hyperglycemia starts in the morning at 04:00. There is no significant difference in the frequency or duration of hypo/hyper glycemia during the day and night irrespective of the timing of glargine injection except pre−breakfast levels are significantly better in the bedtime group and hypoglycemia occurs between midnight and 04:00 in the bedtime group. Conflict of interest:None declared.
format Text
id pubmed-3005638
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-30056382011-01-27 A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes Gökşen Şimşek, Damla Yıldız, Başak Asar, Gülgün Darcan, Şükran J Clin Res Pediatr Endocrinol Original Article Background: Insulin glargine provides effective glycemic control when administered at bedtime in adults. Objective: This study aims to investigate whether insulin glargine is equally effective if administered in the morning or at bedtime in combination with preprandial anologue insulin. Methods: Twenty−eight patients that have been treated with an intensified insulin regimen for at least one year were randomized to insulin glargine injection at breakfast (06:00−09:00) (12 patients) or bedtime (21:00−24:00) (16 patients), plus meal−time anologue insulin in the two groups. Glucose data from each day were analyzed at four different times: between 9:00 and 21:00 (t1), between 21:00 and 24:00 (t2), between 24:00 and 04:00 (t3),04:00 and 09:00 (t4) by the Minimed continuous glucose monitoring system. Results: Baseline characteristics were similar in the two groups. The sensor values were lower before breakfast in the bedtime group (180.5 ± 49.0 vs 223.8 ± 47.3 mg/dl, p=0.03). There were 13.7 events.patient (−1).day(−1) in the bedtime group and 6.9 events.patient (−1).day(−1) in the breakfast group in which glucose levels fell below 60 mg/dl (p=0.3). There were 121.6 events.patient (−1).day(−1) in the bedtime group and 162.4 events.patient (−1).day(−1) in the breakfast group in which glucose levels exceeded 180 mg/dl (p=0.05). Nighttime hypoglycemia only reached to a statistical significance between the two groups between 24:00 and 04:00. There were no significant correlations between the duration of nocturnal hypoglycemia, age, duration of diabetes, gender and HbA1c levels. Conclusion: Breakfast group is hyperglycemic during the day and hyperglycemia starts in the morning at 04:00. There is no significant difference in the frequency or duration of hypo/hyper glycemia during the day and night irrespective of the timing of glargine injection except pre−breakfast levels are significantly better in the bedtime group and hypoglycemia occurs between midnight and 04:00 in the bedtime group. Conflict of interest:None declared. Galenos Publishing 2008-09 2008-08-03 /pmc/articles/PMC3005638/ /pubmed/21318060 http://dx.doi.org/10.4008/jcrpe.v1i1.10 Text en © Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gökşen Şimşek, Damla
Yıldız, Başak
Asar, Gülgün
Darcan, Şükran
A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title_full A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title_fullStr A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title_full_unstemmed A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title_short A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes
title_sort randomized clinical trial comparing breakfast and bedtime administration of insulin glargine in children and adolescents with type 1 diabetes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005638/
https://www.ncbi.nlm.nih.gov/pubmed/21318060
http://dx.doi.org/10.4008/jcrpe.v1i1.10
work_keys_str_mv AT goksensimsekdamla arandomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT yıldızbasak arandomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT asargulgun arandomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT darcansukran arandomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT goksensimsekdamla randomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT yıldızbasak randomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT asargulgun randomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes
AT darcansukran randomizedclinicaltrialcomparingbreakfastandbedtimeadministrationofinsulinglargineinchildrenandadolescentswithtype1diabetes